Masaryk Memorial Cancer Institute

Recent papers from Masaryk Memorial Cancer Institute

1. Clinical nodal findings and indocyanine green-guided sentinel-node mapping in non-metastatic colon cancer: an exploratory prospective cohort stratified by postoperative mismatch-repair statusWorld Journal of Surgical Oncology · 2026
2. Post-search validation of site-resolved N-glycopeptide assigments using complementary LC–MS/MS evidence2026
3. A European multicenter cohort study of patients with oligometastatic prostate cancer receiving stereotactic body radiotherapy for non-spinal bone metastasesStrahlentherapie und Onkologie · 2026
4. The healthcare experience of solid rare cancer patients and their healthcare professionals: quantitative results from the eortc qol rare cancer studyBMC Cancer · 2026
5. Fecal microRNA signatures as non‐invasive diagnostic and prognostic markers of pediatric inflammatory bowel diseasesJournal of Pediatric Gastroenterology and Nutrition · 2026
6. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialThe Lancet · 2000
7. Real‐World HRR Testing Pathways and Patterns of Detected Alterations in Prostate Cancer From the Multinational ARON‐3 StudyThe Prostate · 2026
8. Early dynamics of eosinophils and the neutrophil-to-lymphocyte ratio are associated with severe immune-related adverse events during nivolumab therapy for metastatic renal cell carcinomaFrontiers in Immunology · 2026
9. Uncovering Functional Distant Mutations by Ultrahigh-Throughput Screening of DehalogenasesACS Catalysis · 2026
10. Primary G-CSF prophylaxis in sacituzumab govitecan–treated mTNBC: real-world evidence from a multinational CEBCC-102 cohortSupportive Care in Cancer · 2026
11. Translating avelumab maintenance into clinical practice: nationwide outcomes in Czech patients with advanced or metastatic urothelial carcinomaFuture Oncology · 2026
12. Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 studyThe Lancet · 2015
13. Young Age Is Associated with Improved Survival After Resection of Non-Metastatic Pancreatic Ductal AdenocarcinomaLife · 2026
14. Transmembrane glycoprotein GPNMB is a candidate predictive biomarker and target in metastatic renal cell carcinomaMolecular Medicine · 2026
15. Post-Search Validation and Curation of Site-Resolved N-Glycoproteomics DataJACS Au · 2026
16. Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO StudyJournal of Clinical Oncology · 2026
17. Radiotherapy Modality and Primary Tumor Type as Determinants of Outcomes in Brain Metastases: A Retrospective Study of 734 PatientsMedicina · 2026
18. Cancer-associated synonymous mutations target mRNA structures and protein activityTrends in cancer · 2026
19. Landscape of cancer genomics and precision oncology in EuropeThe Lancet Regional Health - Europe · 2026
20. High-grade serous ovarian cancer is associated with increased TP53 mutation burden in uterine lavagenpj Precision Oncology · 2026